Ingalls & Snyder’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
Other funds holding REPL
BBA
Ingalls & Snyder's REPL Position: Q3 2026 in Review
Ingalls & Snyder sold out of Replimune Group (REPL) in Q3 2026, closing a stake of 3,000 shares — an estimated $37.9K sold.
Ingalls & Snyder first reported a position in REPL in Q2 2026 and held it in 1 quarter. The position peaked at $33K in Q2 2026. 210 funds tracked by Wall St. Rank hold REPL as of Q3 2026.
- Ingalls & Snyder reported no remaining Replimune Group position as of Q3 2026 after selling out during the quarter.
- Ingalls & Snyder sold 3,000 Replimune Group shares in Q3 2026, an estimated $37.9K.
- Ingalls & Snyder first reported a position in Replimune Group in Q2 2026 and held it in 1 quarter.
- Ingalls & Snyder's Replimune Group position peaked at $33K in Q2 2026.
- 210 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.
Based on Ingalls & Snyder's 13F filing for Q3 2026, filed 12 Nov 2026.